[1] |
SUN L, ZHANG Y S, CUI L J,et al. Lifetime and 1-month prevalence of mental disorders in Hebei Province,China:a community-based cross-sectional study[J]. Front Public Health, 2021, 9:759160. DOI: 10.3389/fpubh.2021.759160.
|
[2] |
ZHOU M G, WANG H D, ZENG X Y,et al. Mortality,morbidity,and risk factors in China and its provinces,1990—2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158. DOI: 10.1016/S0140-6736(19)30427-1.
|
[3] |
张蕾,崔牛牛,陈佳鹏. 中国农村贫困人口重点疾病直接经济负担研究[J]. 人口与发展,2022,28(2):2-19.
|
[4] |
YUE J L, YAN W, SUN Y K,et al. Mental health services for infectious disease outbreaks including COVID-19:a rapid systematic review[J]. Psychol Med, 2020, 50(15):2498-2513. DOI: 10.1017/S0033291720003888.
|
[5] |
HUANG Y,WANG Y,WANG H,et al. Prevalence of mental disorders in China:a cross-sectional epidemiological study[J]. The Lancet Psychiatry,2019,6(3):211-224.
|
[6] |
地区精神疾病流行学调查协作组,沈渔邨,陈昌惠,等. 国内12地区精神疾病流行学调查的方法学及资料分析[J]. 中华神经精神科杂志,1986,19(2):65-69.
|
[7] |
|
[8] |
肖兰,张桂青,李丹玉,等. 新疆南疆精神障碍流行病学调查及影响因素分析[J]. 现代预防医学,2021,48(11):1930-1933,2005.
|
[9] |
李涛. 宁夏农村地区成人精神障碍现况调查及其影响因素研究[D]. 银川:宁夏医科大学,2013.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
金华,吴文源,张明园. 中国正常人SCL-90评定结果的初步分析[J]. 中国神经精神疾病杂志,1986,12(5):260-263.
|
[14] |
BOESSEN R, GROENWOLD R H, KNOL M J,et al. Comparing HAMD(17) and HAMD subscales on their ability to differentiate active treatment from placebo in randomized controlled trials[J]. J Affect Disord, 2013, 145(3):363-369. DOI: 10.1016/j.jad.2012.08.026.
|
[15] |
刘盼盼. 女性PFD心理社会影响因素分析及认知行为干预的研究[D]. 石河子:石河子大学,2021.
|
[16] |
|
[17] |
郭丽冰,吴伟博,吴嘉颖,等. 自身免疫性脑炎相关认知和癫痫精神障碍临床研究[J]. 脑与神经疾病杂志,2020,28(9):583-587.
|
[18] |
赵若男. 中风病队列研究中量表数据缺失填补方法及中医药干预效果评价研究[D]. 咸阳:陕西中医药大学,2021.
|
[19] |
李姣. 中药治疗痴呆的精神行为症状疗效与安全性系统评价[D]. 武汉:湖北中医药大学,2020.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
PHILLIPS M R, ZHANG J X, SHI Q C,et al. Prevalence,treatment,and associated disability of mental disorders in four provinces in China during 2001-05:an epidemiological survey[J]. Lancet, 2009, 373(9680):2041-2053. DOI: 10.1016/S0140-6736(09)60660-7.
|
[27] |
|
[28] |
|
[29] |
|
[30] |
YIN H, XU G, TIAN H,et al. The prevalence,age-of-onset and the correlates of DSM-Ⅳ psychiatric disorders in the Tianjin Mental Health Survey(TJMHS)[J]. Psychol Med, 2018, 48(3):473-487. DOI: 10.1017/S0033291717001878.
|
[31] |
|
[32] |
|
[33] |
KOKKOSIS A G, TSIRKA S E. Neuroimmune mechanisms and sex/gender-dependent effects in the pathophysiology of mental disorders[J]. J Pharmacol Exp Ther, 2020, 375(1):175-192. DOI: 10.1124/jpet.120.266163.
|
[34] |
RUBINOW D R, SCHMIDT P J. Sex differences and the neurobiology of affective disorders[J]. Neuropsychopharmacology, 2019, 44(1):111-128. DOI: 10.1038/s41386-018-0148-z.
|
[35] |
|
[36] |
HOWES O D, KAPUR S. The dopamine hypothesis of schizophrenia:versionⅢ:the final common pathway[J]. Schizophr Bull, 2009, 35(3):549-562. DOI: 10.1093/schbul/sbp006.
|
[37] |
CANTOR-GRAAE E. The contribution of social factors to the development of schizophrenia:a review of recent findings[J]. Can J Psychiatry, 2007, 52(5):277-286. DOI: 10.1177/070674370705200502.
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
ZHANG J, WANG R, WANG C,et al. Prevalence of mental disorders in 21st century Shandong Province,China:a ten-year comparative study[J]. J Affect Disord, 2021, 283:344-353. DOI: 10.1016/j.jad.2021.01.068.
|
[45] |
|